The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions


1. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 2. Helios Heart Center, Siegburg, Germany; 3. Institut Cardiovasculaire Paris Sud, Massy, France; 4. Cardialysis B.V., The Netherlands; 5. Tryton Medical, Inc. Newton, MA, USA; 6. Dartmouth Medical

Aim: To report clinical and angiographic follow-up at 6 months after implantation of the Tryton Side-Branch Stent™ dedicated to bifurcation, in conjunction with standard workhorse drug-elut

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
A novel dedicated quantitative coronary analysis methodology for bifurcation lesions

Latest news